Startseite

In 2021, FAU was awarded almost a quarter of a billion euros in third-party funding. With an increase of more than eight percent, this means FAU, which is the largest university in Northern Bavaria, has once again increased the volume of third-party funding it receives.

The Erlangen location of the Bavarian Center for Cancer Research (BZKF) is providing start-up funding worth a total of 110,000 euros to three research projects at Universitätsklinikum Erlangen. The aim of the projects is to conduct fundamental research into new therapeutic approaches for treating cancer.

FAU researchers presented their initial successes in their work for people suffering from myalgic encephalomyelitis/chronic fatigue syndrome. The researchers from Erlangen were able to prove that there are objectively measurable parallels between Long Covid and ME/CFS.